MetaADEDB 2.0 @ LMMD
Fosamax plus D
(HVLYRWMHSQOCIQ-GTYZJCMKSA-M)
Structure
SMILES
CC(CCC[C@H]([C@H]1CC[C@@H]2[C@]1(C)CCC/C/2=C\C=C/1\C[C@@H](O)CCC1=C)C)C.NCCCC(P(=O)(O)O)(P(=O)(O)[O-])O.[Na+]
Molecular Formula:
C31H56NNaO8P2
Molecular Weight:
655.716
Log P:
7.4843
Hydrogen Bond Acceptor:
9
Hydrogen Bond Donor:
6
TPSA:
203.99
CAS Number(s):
871265-91-7
Synonym(s)
1.
Fosamax plus D
External Link(s)
PubChem Compound23682309
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1ArthralgiaFAERS: 49
Canada Vigilance: 6
Canada Vigilance
US FAERS
2MyalgiaFAERS: 40
Canada Vigilance: 2
Canada Vigilance
US FAERS
3Bone painFAERS: 36
Canada Vigilance: 1
Canada Vigilance
US FAERS
4PainFAERS: 23
Canada Vigilance: 3
Canada Vigilance
US FAERS
5Back PainFAERS: 19
Canada Vigilance: 3
Canada Vigilance
US FAERS
6MalaiseFAERS: 16
Canada Vigilance: 3
Canada Vigilance
US FAERS
7AstheniaFAERS: 15US FAERS
8Chest PainFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
9No adverse eventFAERS: 14US FAERS
10FatigueFAERS: 13
Canada Vigilance: 3
Canada Vigilance
US FAERS
11Osteonecrosis of JawFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
12DizzinessFAERS: 12
Canada Vigilance: 3
Canada Vigilance
US FAERS
13Weight decreasedFAERS: 12
Canada Vigilance: 3
Canada Vigilance
US FAERS
14Adverse eventFAERS: 10US FAERS
15NauseaFAERS: 10
Canada Vigilance: 3
Canada Vigilance
US FAERS
16PruritusFAERS: 10
Canada Vigilance: 5
Canada Vigilance
US FAERS
17Drug dose omissionFAERS: 9US FAERS
18HeadacheFAERS: 9
Canada Vigilance: 3
Canada Vigilance
US FAERS
19Musculoskeletal PainFAERS: 9
Canada Vigilance: 3
Canada Vigilance
US FAERS
20OsteomyelitisFAERS: 9US FAERS
21VomitingFAERS: 9
Canada Vigilance: 2
Canada Vigilance
US FAERS
22Musculoskeletal stiffnessFAERS: 8US FAERS
23SepsisFAERS: 8US FAERS
24TachycardiaFAERS: 8US FAERS
25Atrial FibrillationFAERS: 7US FAERS
26Atypical femur fractureFAERS: 7
Canada Vigilance: 4
Canada Vigilance
US FAERS
27Drug ineffectiveFAERS: 7US FAERS
28FractureFAERS: 7US FAERS
29OverdoseFAERS: 7US FAERS
30ChillsFAERS: 6US FAERS
31ClubbingFAERS: 6US FAERS
32DyspepsiaFAERS: 6
Canada Vigilance: 3
Canada Vigilance
US FAERS
33Joint swellingFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
34MalabsorptionFAERS: 6US FAERS
35Musculoskeletal discomfortFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
36Oral painFAERS: 6US FAERS
37Tooth LossFAERS: 6US FAERS
38ArthritisFAERS: 5US FAERS
39Bone density decreasedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
40Burning sensationFAERS: 5US FAERS
41Cerebrovascular accidentFAERS: 5US FAERS
42ErythemaFAERS: 5
Canada Vigilance: 2
Canada Vigilance
US FAERS
43OsteitisFAERS: 5US FAERS
44PalpitationsFAERS: 5US FAERS
45Respiratory FailureFAERS: 5US FAERS
46Acute respiratory failureFAERS: 4US FAERS
47AlopeciaFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
48ConstipationFAERS: 4
Canada Vigilance: 3
Canada Vigilance
US FAERS
49DiscomfortFAERS: 4
Canada Vigilance: 2
Canada Vigilance
US FAERS
50Electrocardiogram abnormalFAERS: 4US FAERS
51Eye painFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
52Feeling abnormalFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
53Gastrointestinal carcinomaFAERS: 4US FAERS
54GingivitisFAERS: 4US FAERS
55Inappropriate schedule of drug administrationFAERS: 4US FAERS
56Memory impairmentFAERS: 4US FAERS
57Myocardial InfarctionFAERS: 4US FAERS
58Open reduction of fractureFAERS: 4US FAERS
59Palmar erythemaFAERS: 4US FAERS
60Pelvic PainFAERS: 4US FAERS
61PneumoniaFAERS: 4US FAERS
62Product quality issueFAERS: 4US FAERS
63TremorFAERS: 4US FAERS
64Urinary tract infectionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
65AbasiaFAERS: 3US FAERS
66Abdominal PainFAERS: 3US FAERS
67Activities of daily living impairedFAERS: 3US FAERS
68BlindnessFAERS: 3US FAERS
69Cardiac ArrestFAERS: 3US FAERS
70Carotid artery occlusionFAERS: 3US FAERS
71Drug administration errorFAERS: 3US FAERS
72DysgeusiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
73Feeling ColdFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
74Inadequate analgesiaFAERS: 3US FAERS
75InfectionFAERS: 3US FAERS
76Intervertebral disc disorderFAERS: 3US FAERS
77Loose toothFAERS: 3US FAERS
78Medication ErrorFAERS: 3US FAERS
79Muscle tightnessFAERS: 3US FAERS
80OsteoporosisFAERS: 3US FAERS
81PancreatitisFAERS: 3US FAERS
82RhabdomyolysisFAERS: 3US FAERS
83Skin hypertrophyFAERS: 3US FAERS
84SynovitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
85ToothacheFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
86TuberculosisFAERS: 3US FAERS
87Urinary RetentionFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
88Urinary Tract PainFAERS: 3US FAERS
89UrticariaFAERS: 3
Canada Vigilance: 3
Canada Vigilance
US FAERS
90Visual ImpairmentFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
91White blood cell count decreasedFAERS: 3US FAERS
92Abdominal discomfortFAERS: 2
Canada Vigilance: 3
Canada Vigilance
US FAERS
93AbscessFAERS: 2US FAERS
94Angina PectorisFAERS: 2US FAERS
95Ankle FractureFAERS: 2US FAERS
96AnxietyFAERS: 2US FAERS
97AphasiaFAERS: 2US FAERS
98ArthropathyFAERS: 2US FAERS
99Back disorderFAERS: 2US FAERS
100Blood pressure fluctuationFAERS: 2US FAERS
101Bone atrophyFAERS: 2US FAERS
102Callus formation delayedFAERS: 2US FAERS
103CataractFAERS: 2US FAERS
104Chest discomfortFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
105Dental cariesFAERS: 2US FAERS
106ElectrocardiogramFAERS: 2US FAERS
107Eye irritationFAERS: 2US FAERS
108Fistula dischargeFAERS: 2US FAERS
109Flank PainFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
110FlatulenceFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
111Gastric ulcerFAERS: 2US FAERS
112GastritisFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
113Gastrointestinal PainFAERS: 2US FAERS
114GlaucomaFAERS: 2US FAERS
115HyperparathyroidismFAERS: 2US FAERS
116Hypertensive crisisFAERS: 2US FAERS
117HypotensionFAERS: 2US FAERS
118Impaired work abilityFAERS: 2US FAERS
119Incorrect dose administeredFAERS: 2US FAERS
120InflammationFAERS: 2US FAERS
121Joint sprainFAERS: 2US FAERS
122Joint stiffnessFAERS: 2US FAERS
123Neck PainFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
124NephrolithiasisFAERS: 2US FAERS
125Non-cardiac chest painFAERS: 2US FAERS
126Oral Cavity FistulaFAERS: 2US FAERS
127Oropharyngeal painFAERS: 2US FAERS
128Pathological fractureFAERS: 2US FAERS
129Pharyngeal StenosisFAERS: 2US FAERS
130Poor quality drug administeredFAERS: 2US FAERS
131Rheumatoid ArthritisFAERS: 2US FAERS
132StomatitisFAERS: 2US FAERS
133SwellingFAERS: 2US FAERS
134Therapy cessationFAERS: 2US FAERS
135TinnitusFAERS: 2US FAERS
136Tooth InfectionFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
137Traumatic fractureFAERS: 2US FAERS
138TrismusFAERS: 2US FAERS
139Walking aid userFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
140Wrong technique in drug usage processFAERS: 2US FAERS
141Wrong technique in product usage processFAERS: 2US FAERS
142Accidental overdoseFAERS: 1US FAERS
143AgitationFAERS: 1US FAERS
144Anaphylactic shockFAERS: 1US FAERS
145AngioedemaFAERS: 1US FAERS
146AphagiaFAERS: 1US FAERS
147AphoniaFAERS: 1US FAERS
148Aphthous StomatitisFAERS: 1US FAERS
149AppendicitisFAERS: 1US FAERS
150AscitesFAERS: 1US FAERS
151AsphyxiaFAERS: 1US FAERS
152BedriddenFAERS: 1US FAERS
153BiopsyFAERS: 1US FAERS
154Blood cholesterol increasedFAERS: 1US FAERS
155Blood gastrin increasedFAERS: 1US FAERS
156Blood urine presentFAERS: 1US FAERS
157Bone density abnormalFAERS: 1US FAERS
158Bone fissureFAERS: 1US FAERS
159Bone formation decreasedFAERS: 1US FAERS
160Bone lesionFAERS: 1US FAERS
161Bone swellingFAERS: 1US FAERS
162Breast cancer recurrentFAERS: 1US FAERS
163Breast cancer stage IIFAERS: 1US FAERS
164C-reactive protein normalFAERS: 1US FAERS
165Carcinoembryonic antigen increasedFAERS: 1US FAERS
166Cardiac ventricular disorderFAERS: 1US FAERS
167CellulitisFAERS: 1US FAERS
168CholelithiasisFAERS: 1US FAERS
169Circumstance or information capable of leading to medication errorFAERS: 1US FAERS
170Compression fractureFAERS: 1US FAERS
171ConjunctivitisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
172CystFAERS: 1US FAERS
173DeafnessFAERS: 1US FAERS
174Decreased immune responsivenessFAERS: 1US FAERS
175Dental prosthesis placementFAERS: 1US FAERS
176DependenceFAERS: 1US FAERS
177Depressed Level of ConsciousnessFAERS: 1US FAERS
178DermatomyositisFAERS: 1US FAERS
179DiplopiaFAERS: 1US FAERS
180DiverticulumFAERS: 1US FAERS
181Drug exposure during pregnancyFAERS: 1US FAERS
182Drug prescribing errorFAERS: 1US FAERS
183DysarthriaFAERS: 1US FAERS
184Electrolyte imbalanceFAERS: 1US FAERS
185Epigastric discomfortFAERS: 1US FAERS
186EpilepsyFAERS: 1US FAERS
187FibromyalgiaFAERS: 1US FAERS
188Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
189GastrectomyFAERS: 1US FAERS
190GastroenteritisFAERS: 1US FAERS
191Gastrointestinal infectionFAERS: 1US FAERS
192Gastrointestinal inflammationFAERS: 1US FAERS
193Gastrointestinal stoma complicationFAERS: 1US FAERS
194GastrostomyFAERS: 1US FAERS
195General physical health deteriorationFAERS: 1US FAERS
196Gingival graftFAERS: 1US FAERS
197Head titubationFAERS: 1US FAERS
198HypersensitivityFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
199HypophagiaFAERS: 1US FAERS
200HypothyroidismFAERS: 1US FAERS
201Implant site painFAERS: 1US FAERS
202Incision site painFAERS: 1US FAERS
203Incorrect drug administration durationFAERS: 1US FAERS
204Incorrect route of drug administrationFAERS: 1US FAERS
205Increased tendency to bruiseFAERS: 1US FAERS
206Intentional drug misuseFAERS: 1US FAERS
207Intestinal resectionFAERS: 1US FAERS
208IridocyclitisFAERS: 1US FAERS
209IritisFAERS: 1US FAERS
210Irritable Bowel SyndromeFAERS: 1US FAERS
211Joint InstabilityFAERS: 1US FAERS
212Joint Range of Motion DecreasedFAERS: 1US FAERS
213Joint injuryFAERS: 1US FAERS
214LaryngitisFAERS: 1US FAERS
215Ligament ruptureFAERS: 1US FAERS
216Low turnover osteopathyFAERS: 1US FAERS
217Musculoskeletal chest painFAERS: 1US FAERS
218NecrosisFAERS: 1US FAERS
219Nephrotic SyndromeFAERS: 1US FAERS
220NervousnessFAERS: 1US FAERS
221Night sweatsFAERS: 1US FAERS
222Oncologic complicationFAERS: 1US FAERS
223Oral infectionFAERS: 1US FAERS
224Oropharyngeal discomfortFAERS: 1US FAERS
225OsteodystrophyFAERS: 1US FAERS
226Osteogenesis ImperfectaFAERS: 1US FAERS
227Paranasal sinus discomfortFAERS: 1US FAERS
228Peri-spinal heterotopic ossificationFAERS: 1US FAERS
229PeriodontitisFAERS: 1US FAERS
230Peripheral swellingFAERS: 1US FAERS
231Peripheral venous diseaseFAERS: 1US FAERS
232Pityriasis Rubra PilarisFAERS: 1US FAERS
233PlasmacytomaFAERS: 1US FAERS
234PolymyositisFAERS: 1US FAERS
235Poor quality sleepFAERS: 1US FAERS
236ProctitisFAERS: 1US FAERS
237Product adhesion issueFAERS: 1US FAERS
238Product blister packaging issueFAERS: 1US FAERS
239Product dose omissionFAERS: 1US FAERS
240Product packaging issueFAERS: 1US FAERS
241Product packaging quantity issueFAERS: 1US FAERS
242Product physical issueFAERS: 1US FAERS
243Product supply issueFAERS: 1US FAERS
244Product use in unapproved indicationFAERS: 1US FAERS
245Product use issueFAERS: 1US FAERS
246RadiculopathyFAERS: 1US FAERS
247Rash erythematousFAERS: 1US FAERS
248Restless Legs SyndromeFAERS: 1US FAERS
249RestlessnessFAERS: 1US FAERS
250Retinal VasculitisFAERS: 1US FAERS
251Retinal vascular thrombosisFAERS: 1US FAERS
252Rheumatoid factor increasedFAERS: 1US FAERS
253SciaticaFAERS: 1US FAERS
254Septic ShockFAERS: 1US FAERS
255ShockFAERS: 1US FAERS
256Skin necrosisFAERS: 1US FAERS
257Spinal column stenosisFAERS: 1US FAERS
258SpondylolysisFAERS: 1US FAERS
259SyncopeFAERS: 1US FAERS
260TachyarrhythmiaFAERS: 1US FAERS
261TensionFAERS: 1US FAERS
262Therapeutic response unexpectedFAERS: 1US FAERS
263Throat irritationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
264Tooth ExtractionFAERS: 1US FAERS
265UlcerFAERS: 1US FAERS
266Urinary IncontinenceFAERS: 1US FAERS
267Uterovaginal prolapseFAERS: 1US FAERS
268UveitisFAERS: 1US FAERS
269Vascular painFAERS: 1US FAERS
270Vitamin D DeficiencyFAERS: 1US FAERS
271intensive careFAERS: 1US FAERS
272Abnormal sleep-related eventCanada Vigilance: 1Canada Vigilance
273BursitisCanada Vigilance: 1Canada Vigilance
274Eye inflammationCanada Vigilance: 1Canada Vigilance
275Facial PainCanada Vigilance: 1Canada Vigilance
276Impaired self-careCanada Vigilance: 1Canada Vigilance
277Lip swellingCanada Vigilance: 1Canada Vigilance
278Pharyngeal swellingCanada Vigilance: 1Canada Vigilance
279Skin reactionCanada Vigilance: 1Canada Vigilance
280Sleep disorder due to general medical condition, insomnia typeCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120269

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.